Skip to main content
Log in

Recent progress in quantitative analysis of DNA adducts of nephrotoxin aristolochic acid

  • Published:
Science in China Series B: Chemistry Aims and scope Submit manuscript

Abstract

Aristolochic acid (AA), a mixture of structure-related nitrophenanthrene carboxylic acid derivatives derived from Aristolochia spp, is associated with nephrotoxin and carcinogen. AA-DNA adducts induced by reductive metabolic activation of AA were detected in tissues of animals and in patients exposed to AA. The DNA adducts were generally used as biomarkers in toxicological study of AA. In this short review, quantitative analysis of AA-DNA adducts in various in vitro and in vivo systems by using 32P-postlabelling assay, HPLC-UV, HPLC-radiation monitor, HPLC-FLD, HPLC-ESI/MS and UPLC-MS/MS methods is discussed. The distribution of AA-DNA adducts in various tissues is also summarized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rucker G, Chung B S. Aristolochic acid from Aristolochia manshuriensi. Planta Med, 1975, 27: 68–71

    Article  CAS  Google Scholar 

  2. Priestap H A. Minor aristolochic acids from Aristolochia argetina and mass spectral analysis of aristolochic acids. Phytochemistry, 1987, 26: 519–529

    Article  CAS  Google Scholar 

  3. Kupchan S M, Doskotch R W. Tumor inhibitors. I. Aristolochic acid, the active principle of Aristolochia indica. J Med Chem, 1962, 5: 657–659

    Article  CAS  Google Scholar 

  4. Kumar V, Ponam D, Prasad A K, Parmar V S. Naturally occurring aristolactams, aristolochic acids and diaxoapophines and their biological activities. Nat Prod Rep, 2003, 20: 565–583

    Article  CAS  Google Scholar 

  5. Kluthe R, Vogt A, Batsford S. Doppelblindstudie zur beeinflussung der phagocytosefahigkeit von granulocyten durch Aristolochiasaure. Drug Res, 1982, 32: 443–445

    CAS  Google Scholar 

  6. Mengs U, Lang W, Poch J A. The carcinogenic action of aristolochic acid in rats. Arch Toxicol, 1982, 107: 107–119

    Article  Google Scholar 

  7. Mengs U. On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid. Arch Toxicol, 1983, 52: 209–220

    Article  CAS  Google Scholar 

  8. Pfau W, Schmeiser H H, Wiessler M. N6-adenyl arylation of DNA by aristolochic acid II and a synthetic model for the putative proximate carcinogen. Chem Res Toxicol, 1991, 4: 581–586

    Article  CAS  Google Scholar 

  9. Bieler C A, Stiborova M, Wiessler M, Cosyns J P, van Ypersele de Strihou C, Schmeiser H H. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcingenesis, 1997, 18: 1063–1067

    Article  CAS  Google Scholar 

  10. Stiborova M, Frei E, Sopko B, Wiessler M, Schmeiser H H. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy. Carcingenesis, 2002, 23: 617–625

    Article  Google Scholar 

  11. Lord G M, Cook T, Arlt V M, Schmeiser H H, Williams G, Pusey C D. Urothelial malignant disease and Chinese herbal nephropathy. Lancet, 2001, 358: 1515–1516

    Article  CAS  Google Scholar 

  12. Debelle F D, Nortier J L, de Prez E G, Garbar C H, Vienne A R, Salmon I J, Deschodt-Lanckman M M, Vanherweghem J L. Aristolochic acid induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol, 2002, 13: 431–436

    CAS  Google Scholar 

  13. Cosyns J P, Dehoux J P, Guiot Y, Goebbels R M, Robert A, Bernard A M, van Ypersele de Strihou C. Chronic aristolochic acid toxicity in rabbits: A model of Chinese herbs nephropathy? Kidney Int, 2001, 59: 2164–2173

    CAS  Google Scholar 

  14. Mengs U. Tumor induction in mice following exposure to aristolochic acid. Arch Toxicol, 1988, 61: 504–505

    Article  CAS  Google Scholar 

  15. Pfau W, Schmeiser H H, Wiessler M. Aristolochic acid binds covalently to the amino group of purine nucleotides in DNA. Carcinogenesis, 1990, 11: 313–319

    Article  CAS  Google Scholar 

  16. Cosyns J P, Jadoul M, Squifflet J P, Wese F X, van Ypersele de Strihou C. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis, 1999, 33: 1011–1017

    Article  CAS  Google Scholar 

  17. Nortier J L, Muniz M C, Schmeiser H H, Arlt V M, Bieler C A, Petein M, Depierreux M F, de Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem J L. Urothelial carcinoma associated with the use of Chinese herbs (Aristolochia species). N Engl J Med, 2000, 342: 1686–1692

    Article  CAS  Google Scholar 

  18. Mengs U. Acute toxicity of aristolochic acid in rodents. Arch Toxicol, 1987, 59: 328–331

    Article  CAS  Google Scholar 

  19. Lebeau C, Arlt V M, Schmeiser H H, Boom A, Verroust P J, Devuyst O, Beauwens R. Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells. Kidney Int, 2001, 60: 1332–1342

    Article  CAS  Google Scholar 

  20. Arlt V M, Alunni-Perret V, Quatrehomme G, Ohayon P, Albano L, Gaid H, Michiels J F, Meyrier A, Cassuto E, Wiessler M, Schmeiser H H, Cosyns J P. Aristolochic acid-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer. Int J Cancer, 2004, 111: 977–980

    Article  CAS  Google Scholar 

  21. Cheng C L, Chen K J, Shih P H, Lu L Y, Hung C F, Lin W C, Gu J Y. Chronic renal failure rats are highly sensitive to aristolochic acids, which are nephrptpxic and carcinogenic agents. Cancer Lett, 2006, 232: 236–242

    Article  CAS  Google Scholar 

  22. Chen L, Mei N, Yao L, Chen T. Mutations induced by carcinogenic doses of aristolochic acid in kidney of big blue transgenic rats. Toxicol Lett, 2006, 165: 250–256

    Article  CAS  Google Scholar 

  23. Wu K Y, Jiang L P, Cao J, Yang G, Geng C Y, Zhong L F. Genotoxic effect and nitrative DNA damage in HepG2 cells exposed to aristolochic acid. Mutat Res, 2007, 630: 97–102

    CAS  Google Scholar 

  24. Chang H R, Lian J D, Lo C W, Huang H P, Wang C J. Aristolochic acid-induced cell cycle G1 arrest in human urothelium SV-HUC-1 cells. Food Chem Toxicol, 2007, 45: 396–402

    Article  CAS  Google Scholar 

  25. Vanherweghem J L, Depierreux M, Tielemans C, Abramowicz D, Vanhaelen-Fastre R, Vanhaelen M. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herb. Lancet, 1993, 341: 381–391

    Article  Google Scholar 

  26. Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem J L. Identication of aristolochic acid in Chinese herbs. Lancet, 1994, 343: 174

    Article  CAS  Google Scholar 

  27. Martinez M C, Nortier J, Vereerstaeten P, Vanherweghem J L. Progression rate of Chinese herb nephropathy: Impact of Aristolochia Fangchi ingested dose. Nephrol Dial Transplant, 2002, 17: 408–412

    Article  Google Scholar 

  28. Cosyns J P. Aristolochic acid and “Chinese herbs nephropathy“: A review of the evidence to date. Drug Saf, 2003, 26: 33–48

    Article  CAS  Google Scholar 

  29. Schmeiser H H, Schoepe K B, Wiessler M. DNA adduct formation of aristolochic acid I and II in vitro and in vivo. Carcinogenesis, 1988, 9: 297–303

    Article  CAS  Google Scholar 

  30. Pfau W, Schmeiser H H, Wiessler M. 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II. Carcinogenesis, 1990, 11: 1627–1633

    Article  CAS  Google Scholar 

  31. Stiborova M, Fernando R C, Schmeiser H H, Frei E, Pfau W, Wiessler M. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-labelling analysis using different chromatographic procedures. Carcinogenesis, 1994, 15: 1187–1192

    Article  CAS  Google Scholar 

  32. Stiborova M, Frei E, Breuer A, Wiessler M, Schmeiser H H. Evidence for reductive activation of carcinogeneic aristolochic acids by prostalandin H synthase-32P-postlabling analysis of DNA adduct formation. Mutat Res, 2001, 493: 149–160

    CAS  Google Scholar 

  33. Stiborova M, Frei E, Sopko B, Spokova K, Markova V, Lankova M, Kumstyrova T, Wiessler M, Schmeiser H H. Human cytosolic enzymes involved in the metabolic activation of carcinogeneic aristolochic acid: Evidence for reductive activation by human NADH: quinine oxidoreductase. Carcinogenesis, 2003, 24: 1695–1703

    Article  CAS  Google Scholar 

  34. Schmeiser H H, Frei E, Wiessler M, Stiborova M. Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by P-32-post-labelling: Evidence for reductive activation by peroxidases. Carcinogenesis, 1997, 18: 1055–1062

    Article  CAS  Google Scholar 

  35. Arlt V M, Pfohl-Leszkowicz A, Cosyns J P, Schmeiser H H. Analysis of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat Res, 2001, 494: 143–150

    CAS  Google Scholar 

  36. Chan W, Zheng Y F, Cai Z W. Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids. J Am Soc Mass Spectrom, 2007, 18: 642–650

    Article  Google Scholar 

  37. Stiborova M, Frei E, Arlt V M, Schmeiser H H. Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy. Mutat Res, 2008, 658: 55–67

    Article  CAS  Google Scholar 

  38. Randerath K, Randerach E, Agrawal H P, Gupta R C, Schurdak M E, Reddy M V. Postlabeling methods for carcinogen-DNA adduct analysis. Environ Health Perspect, 1985, 63: 57–65

    Article  Google Scholar 

  39. Fernando R C, Schmeiser H H, Nicklas W, Wiessler M. Detection and quantitation of dG-AAI and dA-AAI adducts by 32P-postlabeling methods in urothelium and exfoliated cells in urine of rats treated with aristolochic acid I. Carcinogenesis, 1992, 13: 1835–1839

    Article  CAS  Google Scholar 

  40. Mei N, Arlt V M, Phillips D H, Heflich R H, Chen T. DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver. Mutat Res, 2006, 602: 83–91

    CAS  Google Scholar 

  41. Dong H, Suzuki N, Torres M C, Bonala R R, Johnson F, Grollman A P, Shibutani S. Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling/polyacrylamide gel electrophoresis analysis. Am Soc Pharmacol Experiment Therapeut, 2006, 34: 1122–1127

    CAS  Google Scholar 

  42. Stiborova M, Frei E, Hodek P, Wiessler M, Schmeiser H H. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH: Cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer. Int J Cancer, 2005, 113: 189–197

    Article  CAS  Google Scholar 

  43. Fernando R C, Schmeiser H H, Scherf H R, Wiessler M. Formation and persistence of specific purine DNA-adducts by 32P-postlabeling in target and non-target organs in rats treated with aristolochic acid I. IARC Sci Pub1, 1993, 124: 167–171

    CAS  Google Scholar 

  44. Schmeiser H H, Bieler C A, Wiessler M, van Ypersele de strihou C, anctiond Cosyns J P. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res, 1996, 56: 2025–2028

    CAS  Google Scholar 

  45. Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, Peraica M, Castegnaro M, Stefanovic V. New molecular and field evidence for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. Mol Nutr Food Res, 2007, 51: 1131–1146

    Article  CAS  Google Scholar 

  46. Stiborova M, Sopko B, Hodek P, Frei E, Schmeiser H H, Hudecek J. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen. Cancer Lett, 2005, 229: 193–204

    Article  CAS  Google Scholar 

  47. Stiborova M, Frei E, Wiessler M, Schmeiser H H. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: Evidence for reductive activation by cytochromes P450 1A1 and 1A2. Chem Res Toxicol, 2001, 14: 1128–1137

    Article  CAS  Google Scholar 

  48. Zeisig M, Moller L. 32P-HPLC suitable for characterization of DNA adducts formed in vitro by polycyclic aromatic hydrocarbons and derivatives. Carcinogenesis, 1995, 16: 1–9

    Article  CAS  Google Scholar 

  49. Chan W, Lee K C, Liu N, Cai Z W. A sensitivity enhanced high-performance liquid chromatography fluorescence method for the detection of nephrotoxic and carcinogenic aristolochic acid in herbal medicines. J Chromatogr A, 2007, 1164: 113–119

    Article  Google Scholar 

  50. Yuan J B, Liu Q, Zhu W F, Ding L, Tang F, Yao S Z. Simultaneous analysis of six aristolochic acids and five aristolactams in herbal plants and their preparations by high-performance liquid chromatogphy-diode array detection-fluorescence detection. J Chromatogr A, 2008, 1182: 85–92

    Article  CAS  Google Scholar 

  51. Chaudhary A K, Nokubo M, Oglesby T D, Marnett L J, Blair I A. Characterization of endogenous DNA-adducts by liquid-hromagraphy electrospray-ionization tandem mass spectrometry. J Mass Spectrom, 1995, 30: 1157–1166

    Article  CAS  Google Scholar 

  52. Paehler A, Richoz J, Soglia J, Vourous P. Analysis and quantification of DNA adducts of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in liver of rats by liquid chromatography/electrospray tandem mass spectrometry. Chem Res Toxicol, 2002, 15: 551–561

    Article  CAS  Google Scholar 

  53. Qiu S X, Yang R Z, Gross M L. Synthesis and liquid chromatography/tandem mass spectrometric characterization of the adducts of bisphenol A o-quinone with glutathione and nucleotide monophosphates. Chem Res Toxicol, 2004, 17: 1038–1046

    Article  CAS  Google Scholar 

  54. Tompkins E M, Jones D J L, Lamb J H, Marsden D A, Farmer P B, Brown K. Simultaneous detection of five different 2-ydroxyethyl-NA adducts formed by ethylene oxide exposure, using a high-erfornce liquid chromatography/electrospray ionization tandem mass spectrometry assay. Rapid Commun Mass Spectrom, 2008, 22: 19–28

    Article  CAS  Google Scholar 

  55. Zhang F G, Stott W T, Clark A J, Schisler M R, Grundy J J, Gollapudi B B, Bartels M J. Quantitation of 8-hydroxydeoxyguanoisine in DNA by liquid chromatography/positive atmospheric pressure photoionization tandem mass spectrometry. Commun Mass Spectrom, 2007, 21: 3949–3955

    Article  CAS  Google Scholar 

  56. Chan W, Cui L, Xu G W, Cai Z W. Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry. Commun Mass Spectrom, 2006, 20: 1755–1760

    Article  CAS  Google Scholar 

  57. Chan W, Yue H, Poon W T, Chan Y W, Schmitz O J, Kwong D W J, Wong R N S, Cai Z W. Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry. Mutat Res, 2008, 646: 17–24

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to ZongWei Cai.

Additional information

Supported by the Research Grant Council, University Grants Committee of Hong Kong (Grant No. HKBU2459/06M), and the Health and Health Services Research Fund of Hong Kong (Grant No. 05060141)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yue, H., Chan, W., Yu, K. et al. Recent progress in quantitative analysis of DNA adducts of nephrotoxin aristolochic acid. Sci. China Ser. B-Chem. 52, 1576–1582 (2009). https://doi.org/10.1007/s11426-009-0233-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11426-009-0233-6

Keywords

Navigation